JACOBS LEVY EQUITY MANAGEMENT, INC - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q1 2022$5,316,000
-48.3%
612,496
-32.6%
0.04%
-47.8%
Q4 2021$10,274,000
-16.4%
908,432
-7.1%
0.07%
-16.9%
Q3 2021$12,285,000
+50.3%
977,363
-2.9%
0.08%
+50.9%
Q2 2021$8,173,000
-16.7%
1,006,479
-5.1%
0.06%
-27.6%
Q1 2021$9,810,000
+60.7%
1,060,554
+68.0%
0.08%
+40.7%
Q4 2020$6,104,000
-23.9%
631,282
-2.3%
0.05%
-34.9%
Q3 2020$8,022,000
+134.8%
646,413
+146.0%
0.08%
+124.3%
Q2 2020$3,416,000
+263.0%
262,778
+183.4%
0.04%
+208.3%
Q1 2020$941,000
-25.9%
92,733
+14.1%
0.01%0.0%
Q4 2019$1,270,00081,2650.01%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,320,608$41,209,00011.15%
Boxer Capital, LLC 2,562,358$31,799,0001.10%
Integral Health Asset Management, LLC 200,000$2,482,0000.76%
Palo Alto Investors LP 1,077,200$13,368,0000.73%
Artal Group S.A. 2,358,968$29,275,0000.71%
HHLR ADVISORS, LTD. 7,420,974$92,094,0000.70%
MASTERS CAPITAL MANAGEMENT LLC 700,000$8,687,0000.58%
Ikarian Capital, LLC 582,494$7,229,0000.52%
CLOUGH CAPITAL PARTNERS L P 459,834$5,707,0000.41%
Alyeska Investment Group, L.P. 1,173,301$14,561,0000.22%
View complete list of GOSSAMER BIO INC shareholders